Form 4: Haemonetics Corp Executive Maryanne Maunsell Farris Reports Stock Transactions

Maryanne Maunsell Farris, VP and Chief Accounting Officer of Haemonetics Corp, reports disposition of shares to cover tax obligations related to vesting restricted stock units.

Summary

• On May 15, 2025, Maryanne Maunsell Farris, VP, Chief Accounting Officer of Haemonetics Corp, disposed of 60 shares of common stock at a price of $69.38 to cover tax obligations.
• Following this transaction, Ms. Farris directly owns 1,084 shares of common stock, including unvested RSUs.
• On May 16, 2025, Ms. Farris disposed of 68 shares of common stock at a price of $70.31 to cover tax obligations.
• Following this transaction, Ms. Farris directly owns 1,016 shares of common stock, including unvested RSUs.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, which carries a neutral sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions have a minimal impact on stakeholders as they are related to tax obligations from vesting RSUs.

Key Dates

Keywords

Form 4, Beneficial Ownership, Haemonetics Corp, HAE, Maryanne Maunsell Farris, Stock Transaction, Restricted Stock Units, Tax Obligations